Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults
JACC · 2026-08
DOI: 10.1016/j.jacc.2026.06.037 ↗Kurz gefasst
Leitlinie in der Zeitschrift JACC, 2026-08. Verfasst von Ahmed Sayed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rochester General Hospital, Rochester, New York, USA. Electronic address: ahmed.sayed@rochesterregional.org. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Rochester General Hospital, Rochester, New York, USA. Electronic address: ahmed.sayed@rochesterregional.org.
- Department of Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Zitieren
APA
Sayed, A., Peterson, E. D., & Navar, A. M. (2026). Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults. JACC. https://doi.org/10.1016/j.jacc.2026.06.037
Vancouver
Sayed A, Peterson ED, Navar AM. Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults. JACC. 2026. doi:10.1016/j.jacc.2026.06.037
BibTeX
@article{Sayed2026,
author = {Sayed, Ahmed and Peterson, Eric D and Navar, Ann Marie},
title = {Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults},
journal = {JACC},
year = {2026},
doi = {10.1016/j.jacc.2026.06.037}
}
EUVIMED